PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Recently Added NEW Latest cases added to the library
AUTH/3282/11/19
Gilead Sciences Europe
Social Media & Digital · 2019
▶ Video 🎧 Podcast
AUTH/2991/11/17
Pfizer
Samples & Gifts · 2015
▶ Video 🎧 Podcast
AUTH/2082/1/08
Recordati Pharmaceuticals
Promotional Material · 2019
▶ Video 🎧 Podcast
AUTH/2079/1/08
Gamble Pharmaceuticals UK
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2102/2/08
Meda Pharmaceuticals
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2149/7/08
Syner-Med
Promotional Material · 2008
▶ Video 🎧 Podcast
AUTH/2428/8/11
AstraZeneca
Scientific Information · 2008
▶ Video 🎧 Podcast
AUTH/1899/10/06
AstraZeneca
Samples & Gifts · 2019
▶ Video 🎧 Podcast
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 31 results · Ophthalmology  · Clear
🔒 Subscribers only
AUTH/3873/01/24
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable complainant (self-described health professional) said a patient brought a printout of the Eylea Summary of Product Characteristics (SmPC/SPC).The patient allegedly fou…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3897/5/24
Patient Organisations Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Roche breached Clause 25.3 after BBC radio programme lacked clear sponsorship declaration from the o
An anonymous complainant alleged that a BBC radio/audio programme about a campaign sponsored by Roche featured interviews with campaign partners but did not declare Roche’s involvement from the o…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3764/4/23
Off-label Promotion Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Roche
Bayer complained about three faricimab (Vabysmo) promotional claims used by Roche in two materials: a 53-slide promotional slide deck and a sponsored promotional supplement (consensus document) in …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3851/11/23
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Roche
A health professional complained about two National Ophthalmology Database (NOD) AMD audit outputs funded by Roche: (1) a full annual audit report and (2) a patient summary.The complainant alleged …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3809/8/23
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, contactable complainant challenged a Bayer advisory board held on 31 July 2023 in Seattle, USA, alongside the ASRS congress. The complainant alleged the meeting was not a genuine advi…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3461/1/21
Patient Organisations Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Santen
A health professional complained about a wrap-around journal advertisement for Cosopt (dorzolamide and timolol) in The Ophthalmologist (Dec 2020) (ref PP-CSPT-UK-0006).The wrap-around was visible t…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3460/1/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Novartis
A complainant (described themself as a health professional) challenged a Novartis Pharmaceuticals UK journal advertisement for Beovu (brolucizumab) placed in the December 2020 issue of the British …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3464/1/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Novartis breached ABPI Code after edited Beovu HCP video omitted safety caution (AUTH/3464/1/21)
A healthcare practitioner complained about a Novartis promotional Beovu (brolucizumab) website hosting an edited HCP video titled ‘First experience in [country]: Patient cases and implementation�…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3493/3/21
Social Media & Digital Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
AbbVie
A complainant provided screenshots alleging a named senior UK employee of AbbVie had promoted Durysta (sustained release bimatoprost implant) on LinkedIn.The employee ‘liked’ a LinkedIn post by…
Clauses: 9.1,9.2,26.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3531/7/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Anonymous v Novartis
An anonymous, non-contactable complainant (described as an optometrist) challenged Novartis promotional materials for Lucentis (ranibizumab) seen in UK ophthalmic journals and on a Novartis HCP web…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3366/7/20
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer v Novartis
Bayer complained about a Novartis journal advertisement for Beovu (brolucizumab) in Eye News (April 2020), ref BRO20-CO22 (March 2020). The ad included a prominent headline claim in dark pink: “O…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3435/12/20
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Alimera
A UK health professional complained about Alimera’s Iluvien (fluocinolone acetonide) intravitreal implant website (iluvien.co.uk).The landing page offered two routes: “For UK Healthcare Profess…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3334/4/20
Patient Organisations Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Rayner
A health professional received a posted copy of Eye News with a wraparound “bellyband” advertisement for Ilube (acetylcysteine eye drops).The advertisement was visible through the unopened, tra…
Clauses: 9.1
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3207/6/19
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Santen
An anonymous, non-contactable complainant (described as a concerned physician) complained about Santen UK employees’ conduct at the 2019 Royal College of Ophthalmologists (RCOphth) meeting and a …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/2968/8/17
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bausch & Lomb
A letter in The Pharmaceutical Journal (July 2017) criticised Bausch & Lomb’s claims that Emerade (adrenaline auto-injector) had a 30-month shelf-life versus 18 months for EpiPen.The complain…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2893/11/16
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
GE Healthcare
An anonymous, non-contactable complainant alleged GE Healthcare promoted Vizamyl (18F flutemetamol) and/or unlicensed 18F flutemetamol injection to UK PET centres and at the EANM congress (Barcelon…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2785/8/15
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable consultant complained about Bayer’s promotion of Eylea (aflibercept), alleging discussions comparing Eylea with Lucentis (ranibizumab) using off-licence/off-label da…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2748/2/15
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer v Novartis
Bayer complained about claims made by Novartis Pharmaceuticals UK Ltd at two Novartis Pharma AG-sponsored symposia at the EURETINA congress in London (11–14 September 2014) comparing safety of Lu…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2718/5/14
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Allergan
An anonymous, non-contactable complainant alleged Allergan inappropriately approved materials and selected delegates for a neuroscience/ophthalmology-related training meeting.It was alleged the mee…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2642/9/13
Data & Publications Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Novartis
Novartis Pharmaceuticals UK Ltd voluntarily admitted that the September 2013 edition of Ophthalmology Times Europe bore advertising for Lucentis (ranibizumab) on three pages.Novartis’ global team…
Clauses: 27.1
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2390/2/11
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Alcon
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2389/2/11
Off-label Promotion Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Alcon
Allergan complained about an Alcon promotional campaign for Travatan (travaprost preserved with Polyquad) featuring a thornless rose with 13 thorns at the base, used in an advertisement in the Brit…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2372/11/10
HCP Hospitality & Meetings Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Alcon
A former employee alleged Alcon promoted a reformulated Travatan (travoprost) preserved with Polyquad (described as “BAK-free”) before the marketing authorisation variation was granted.At a 30 …
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2343/8/10
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Allergan
Complainant: Ipsen.Company complained about: Allergan.Subject matter: Promotion of Vistabel.Complaint received: 08 April 2010.PMCPA concluded the matter was outwith the scope of the Code.
Clauses: NONE
2010 🔒 Subscribe
1 2 Next → Page 1 of 2 — 31 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews